Cogent Biosciences(COGT.US)

Event Tracking

Jan2

Cogent Biosciences CSO Sells Shares, Raises Concerns Among Shareholders

12:47

Dec31

Cogent Biosciences' Management Engages in Significant Insider Selling

03:26

Dec30

Cogent Biosciences Submits NDA for Berzuclascitinib to FDA

13:01

Dec8

Cogent Biosciences Announces Positive Results for Bezuroclastinib in ADVSM Trial

12:33

Dec6

Cogent Biosciences Announces Positive Results for bezuclastinib in SUMMIT Trial

14:38

Dec2

Virtus Investment Advisers LLC Reduced Holdings in Cogent Biosciences in Q2

12:56

Schedules & Filings

Schedules

Filings

Nov3

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -80.93 M, EPS -0.588

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -73.53 M, EPS -0.6419

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -71.99 M, EPS -0.6348

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change